Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

about

Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy.

P2860

Q53555752-D1D034AD-0B59-442A-A614-C5E1A8D07FD2

P2860

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

Item

http://www.wikidata.org/entity/Q36403043

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@ast

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@en

type

Item

label

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@ast

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@en

prefLabel

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@ast

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@en

P1476

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

@en

P2093

Hee Cheol Kim

http://www.w3.org/2001/XMLSchema#string

Ho-Kyung Chun

http://www.w3.org/2001/XMLSchema#string

Kyung Ook Jung

http://www.w3.org/2001/XMLSchema#string

Seong Hyeon Yun

http://www.w3.org/2001/XMLSchema#string

Woo Yong Lee

http://www.w3.org/2001/XMLSchema#string

Yong Beom Cho

http://www.w3.org/2001/XMLSchema#string

Yoo Sung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Revised TN categorization for colon cancer based on national survival outcomes data.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Capecitabine as adjuvant treatment for stage III colon cancer.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Cellular and molecular aspects of drugs of the future: oxaliplatin.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Prediction of cancer incidence and mortality in Korea, 2011.

Can capecitabine replace 5-FU/leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer?

Challenges in the management of stage II colon cancer

P304

259-264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3393/JKSC.2012.28.5.259

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233775883

http://www.w3.org/2001/XMLSchema#string

P698

23185706

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

3499427

http://www.w3.org/2001/XMLSchema#string

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

about

P2860

P2860

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932